Sign in

CIK 0001783328

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

TScan Therapeutics, Inc.

Sign in to watch
Ticker
TCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825282075
Phone
+1 857-399-9500
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-06-01 Harel Ittai Director Grant or award · Stock Option (Right to Buy) +9,146 9,146
2022-05-18 SOUTHWELL DAVID P Chief Executive Officer Purchase +15,000 $3.62 $54K 161,569
2022-05-18 SOUTHWELL DAVID P Chief Executive Officer Purchase +10,000 $3.55 $35K 171,569
2022-05-11 BAKER BROS. ADVISORS LP Director Purchase +2,882 $1.99 $6K 256,209
2022-05-11 BAKER BROS. ADVISORS LP Director Purchase +22,983 $1.99 $46K 2,528,583
2022-05-10 BAKER BROS. ADVISORS LP Director Purchase +40,800 $1.70 $69K 145,498
2022-05-10 BAKER BROS. ADVISORS LP Director Purchase +325,373 $1.70 $553K 1,645,675
2022-05-10 BAKER BROS. ADVISORS LP Director Purchase +12,769 $1.93 $25K 158,267
2022-05-10 BAKER BROS. ADVISORS LP Director Purchase +101,831 $1.93 $197K 1,747,506
2022-05-10 BAKER BROS. ADVISORS LP Director Purchase +95,060 $1.95 $185K 253,327
2022-05-10 BAKER BROS. ADVISORS LP Director Purchase +758,094 $1.95 $1.5M 2,505,600
2022-03-24 Silver Brian M. Chief Financial Officer Purchase +15,000 $3.40 $51K 26,885
2022-01-18 Desmarais William Chief Business Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2022-01-18 MacBeath Gavin Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +140,000 140,000
2022-01-18 Silver Brian M. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +115,000 115,000
2022-01-18 SOUTHWELL DAVID P Chief Executive Officer Grant or award · Stock Option (Right to Buy) +275,000 275,000
2022-01-18 ZDRAVESKI ZORAN Chief Legal Officer Grant or award · Stock Option (Right to Buy) +85,000 85,000
2021-12-23 SOUTHWELL DAVID P Chief Executive Officer Option exercise +48,670 $1.97 $96K 146,569
2021-12-23 SOUTHWELL DAVID P Chief Executive Officer Option exercise · Stock Option (Right to Buy) −48,670 21,161
2021-09-23 ZDRAVESKI ZORAN Chief Legal Officer Purchase +4,716 $7.48 $35K 4,716

Page 6 of 8 · 144 trades